The board of the AIM-listed medical cannabis company, Celadon Pharmaceuticals, has resigned en masse after a significant internal dispute with the company’s CEO over an imminent de-listing proposal. The decision
The board of the AIM-listed medical cannabis company, Celadon Pharmaceuticals, has resigned en masse after a significant internal dispute with the company’s CEO over an imminent de-listing proposal. The decision






